1. Globocan,2020
2. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases;Chalasani;Hepatology (Baltimore, Md.),2018
3. From NASH to HCC: current concepts and future challenges;Anstee;Nat Rev Gastroenterol Hepatol,2019
4. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030;Estes;J Hepatol,2018
5. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology (Baltimore, Md.),2016